New Market Study Published: Epithelial Ovarian Cancer - Pipeline Review, H2 2012
Global Markets Direct's, 'Epithelial Ovarian Cancer - Pipeline Review, H2 2012', provides an overview of the Epithelial Ovarian Cancer therapeutic pipeline. This report provides information on the therapeutic development for Epithelial Ovarian Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Epithelial Ovarian Cancer. 'Epithelial Ovarian Cancer - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases,...
View full press release